Visibility Score
44/100
AI Mentions
127
AI Search Volume
25.6K
As of June 25, 2026, Embecta (embecta.com) has an AI visibility score of 44 out of 100, based on 127 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 25.6K AI search volume. Compared to peers in the life sciences sector, Embecta ranks #4 of 6 in AI mention share of voice.
Embecta is a US-based medical device company in the Patient Monitoring segment, registered with the U.S. FDA. This report tracks how Embecta appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
Embecta has 127 total AI mentions across 2 tracked platforms, generating 25.6K in AI search volume. Google AI Overview accounts for the largest share at 95% of mentions.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About Embecta
When AI assistants answer questions involving Embecta, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Share of Voice vs Competitors
Embecta ranks #4 out of 6 competitors in AI mention share of voice, capturing 1% of total mentions. Dexcom leads with 7.8K AI mentions. Competitors tracked include Dexcom, Mindray, Masimo, Tandem Diabetes Care.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| dexcom.com (Dexcom) | 7.8K | 14.7M |
| mindray.com (Mindray) | 985 | 505.0K |
| masimo.com (Masimo) | 430 | 94.2K |
| embecta.com (You) | 127 | 25.6K |
| tandemdiabetes.com (Tandem Diabetes Care) | 85 | 1.5K |
| nihonkohden.com (Nihon Kohden) | 60 | 6.9K |
Improve your brand's AI visibility
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.